• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于部分可观测马尔可夫决策过程(POMDP)模型的慢性病诊断策略优化

Diagnostic Policies Optimization for Chronic Diseases Based on POMDP Model.

作者信息

Zhang Wenqian, Wang Haiyan

机构信息

School of Economics and Management, Southeast University, Nanjing 211189, China.

出版信息

Healthcare (Basel). 2022 Feb 1;10(2):283. doi: 10.3390/healthcare10020283.

DOI:10.3390/healthcare10020283
PMID:35206897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8872177/
Abstract

During the process of disease diagnosis, overdiagnosis can lead to potential health loss and unnecessary anxiety for patients as well as increased medical costs, while underdiagnosis can result in patients not being treated on time. To deal with these problems, we construct a partially observable Markov decision process (POMDP) model of chronic diseases to study optimal diagnostic policies, which takes into account individual characteristics of patients. The objective of our model is to maximize a patient's total expected quality-adjusted life years (QALYs). We also derive some structural properties, including the existence of the diagnostic threshold and the optimal diagnosis age for chronic diseases. The resulting optimization is applied to the management of coronary heart disease (CHD). Based on clinical data, we validate our model, demonstrate how the quantitative tool can provide actionable insights for physicians and decision makers in health-related fields, and compare optimal policies with actual clinical decisions. The results indicate that the diagnostic threshold first decreases and then increases as the patient's age increases, which contradicts the intuitive non-decreasing thresholds. Moreover, diagnostic thresholds were higher for women than for men, especially at younger ages.

摘要

在疾病诊断过程中,过度诊断会导致潜在的健康损失、给患者带来不必要的焦虑以及增加医疗成本,而诊断不足则会导致患者无法及时得到治疗。为了解决这些问题,我们构建了一个慢性病的部分可观测马尔可夫决策过程(POMDP)模型来研究最优诊断策略,该模型考虑了患者的个体特征。我们模型的目标是使患者的总预期质量调整生命年(QALY)最大化。我们还推导了一些结构性质,包括慢性病诊断阈值的存在性和最优诊断年龄。所得的优化方法应用于冠心病(CHD)的管理。基于临床数据,我们验证了我们的模型,展示了这种定量工具如何能为健康相关领域的医生和决策者提供可操作的见解,并将最优策略与实际临床决策进行比较。结果表明,诊断阈值随着患者年龄的增加先降低后升高,这与直观的非递减阈值相矛盾。此外,女性的诊断阈值高于男性,尤其是在较年轻的年龄段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a578/8872177/bc879ed2c814/healthcare-10-00283-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a578/8872177/a77f048c793d/healthcare-10-00283-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a578/8872177/94be28a42e6d/healthcare-10-00283-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a578/8872177/28172917df88/healthcare-10-00283-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a578/8872177/3280305db652/healthcare-10-00283-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a578/8872177/72c84ff2ba1b/healthcare-10-00283-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a578/8872177/6bd72e0e181c/healthcare-10-00283-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a578/8872177/bc879ed2c814/healthcare-10-00283-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a578/8872177/a77f048c793d/healthcare-10-00283-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a578/8872177/94be28a42e6d/healthcare-10-00283-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a578/8872177/28172917df88/healthcare-10-00283-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a578/8872177/3280305db652/healthcare-10-00283-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a578/8872177/72c84ff2ba1b/healthcare-10-00283-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a578/8872177/6bd72e0e181c/healthcare-10-00283-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a578/8872177/bc879ed2c814/healthcare-10-00283-g007a.jpg

相似文献

1
Diagnostic Policies Optimization for Chronic Diseases Based on POMDP Model.基于部分可观测马尔可夫决策过程(POMDP)模型的慢性病诊断策略优化
Healthcare (Basel). 2022 Feb 1;10(2):283. doi: 10.3390/healthcare10020283.
2
An alternative approach identified optimal risk thresholds for treatment indication: an illustration in coronary heart disease.另一种方法确定了治疗指征的最佳风险阈值:冠心病的说明。
J Clin Epidemiol. 2018 Feb;94:122-131. doi: 10.1016/j.jclinepi.2017.09.020. Epub 2017 Oct 3.
3
Optimal Policies for Reducing Unnecessary Follow-up Mammography Exams in Breast Cancer Diagnosis.减少乳腺癌诊断中不必要的随访乳房X光检查的优化策略。
Decis Anal. 2013 Sep;10(3):200-224. doi: 10.1287/deca.2013.0272.
4
Optimization of PSA screening policies: a comparison of the patient and societal perspectives.PSA 筛查政策的优化:患者和社会观点的比较。
Med Decis Making. 2012 Mar-Apr;32(2):337-49. doi: 10.1177/0272989X11416513. Epub 2011 Sep 20.
5
From data to optimal decision making: a data-driven, probabilistic machine learning approach to decision support for patients with sepsis.从数据到最优决策:一种数据驱动的、概率机器学习方法,用于支持脓毒症患者的决策。
JMIR Med Inform. 2015 Feb 24;3(1):e11. doi: 10.2196/medinform.3445.
6
Mitigating Nonattendance Using Clinic-Resourced Incentives Can Be Mutually Beneficial: A Contingency Management-Inspired Partially Observable Markov Decision Process Model.利用诊所资源激励措施减少缺勤可能是互惠互利的:基于Contingency Management 的部分可观察马尔可夫决策过程模型。
Value Health. 2021 Aug;24(8):1102-1110. doi: 10.1016/j.jval.2021.03.014. Epub 2021 Jun 28.
7
The Effect of Budgetary Restrictions on Breast Cancer Diagnostic Decisions.预算限制对乳腺癌诊断决策的影响。
Manuf Serv Oper Manag. 2012 Apr;14(4):600-617. doi: 10.1287/msom.1110.0371.
8
Generating Reward Functions Using IRL Towards Individualized Cancer Screening.使用逆强化学习生成奖励函数以实现个性化癌症筛查。
Artif Intell Health (2018). 2019;11326:213-227. doi: 10.1007/978-3-030-12738-1_16. Epub 2019 Feb 21.
9
The Arthroplasty Candidacy Help Engine tool to select candidates for hip and knee replacement surgery: development and economic modelling.人工关节置换候选帮助引擎工具选择髋关节和膝关节置换手术的候选者:开发和经济建模。
Health Technol Assess. 2019 Jun;23(32):1-216. doi: 10.3310/hta23320.
10

本文引用的文献

1
Estimation of Human Mobility Patterns for Forecasting the Early Spread of Disease.用于预测疾病早期传播的人类流动模式估计
Healthcare (Basel). 2021 Sep 16;9(9):1224. doi: 10.3390/healthcare9091224.
2
Different Roles of Telehealth and Telemedicine on Medical Tourism: An Empirical Study from Azerbaijan.远程医疗和远程医学在医疗旅游中的不同作用:来自阿塞拜疆的实证研究。
Healthcare (Basel). 2021 Aug 20;9(8):1073. doi: 10.3390/healthcare9081073.
3
Primary Care Networks and Starfield's 4Cs: A Case for Enhanced Chronic Disease Management.
初级保健网络和 Starfield 的 4Cs:增强慢性病管理的案例。
Int J Environ Res Public Health. 2021 Mar 12;18(6):2926. doi: 10.3390/ijerph18062926.
4
Personalized treatment for coronary artery disease patients: a machine learning approach.冠状动脉疾病患者的个体化治疗:机器学习方法。
Health Care Manag Sci. 2020 Dec;23(4):482-506. doi: 10.1007/s10729-020-09522-4. Epub 2020 Oct 10.
5
COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.COVID-19 与心脏损伤:临床表现、生物标志物、发病机制、诊断、治疗和随访。
Expert Rev Anti Infect Ther. 2021 Mar;19(3):345-357. doi: 10.1080/14787210.2020.1822737. Epub 2020 Sep 28.
6
CT coronary angiography in asymptomatic male patients with high atherosclerosis risk: Is it justified?无症状高动脉粥样硬化风险男性患者的CT冠状动脉造影:是否合理?
Hellenic J Cardiol. 2021 Mar-Apr;62(2):129-134. doi: 10.1016/j.hjc.2020.04.004. Epub 2020 Apr 15.
7
A cardiovascular disease risk prediction algorithm for use with the Medicare current beneficiary survey.一种用于医疗保险当前受益人大调查的心血管疾病风险预测算法。
Health Serv Res. 2020 Aug;55(4):568-577. doi: 10.1111/1475-6773.13290. Epub 2020 Apr 14.
8
Diagnostic coronary angiography and percutaneous coronary intervention practices in New Zealand: The All New Zealand Acute Coronary Syndrome-Quality Improvement CathPCI registry 3-year study (ANZACS-QI 37).新西兰的诊断性冠状动脉造影和经皮冠状动脉介入治疗实践:全新西兰急性冠状动脉综合征-质量改进心脏导管介入注册研究3年研究(ANZACS-QI 37)
Int J Cardiol. 2020 Aug 1;312:37-41. doi: 10.1016/j.ijcard.2020.02.063. Epub 2020 Feb 29.
9
Dynamic Monitoring and Control of Irreversible Chronic Diseases with Application to Glaucoma.不可逆性慢性病的动态监测与控制及其在青光眼方面的应用
Prod Oper Manag. 2019 May;28(5):1082-1107. doi: 10.1111/poms.12975. Epub 2018 Nov 16.
10
Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States.在美国,用多效药丸对心血管疾病二级预防的成本效果和预算影响建模。
Am Heart J. 2019 Aug;214:77-87. doi: 10.1016/j.ahj.2019.04.020. Epub 2019 May 7.